Program Description & Educational Objectives
This interactive educational activity will provide an update on the latest research on the benefits of the standard and investigational therapies for patients with MS. Additionally, current perspectives on cognitive impairment in patients with MS and strategies that may have a role in preservation of cognitive function or treatment of cognitive impairment will be addressed.
Upon completion of this activity, participants will be able to:
- Evaluate the benefits of the established disease-modifying agents (DMAs) in patients with multiple sclerosis (MS)
- Analyze and interpret clinical data pertaining to emerging therapies under investigation for the treatment of MS
- Assess the benefits of various nonpharmacologic and pharmacologic strategies for the preservation and improvement of cognitive function in patients with MS
Target Audience
This activity has been designed to meet the educational needs of US neurologists, advance practice nurses, and other clinicians involved in managing patients with multiple sclerosis.
Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CNE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Media: Internet
Release and Expiration Dates: February 25, 2010 - February 24, 2011
Time to Complete: 30 minutes
Faculty & Disclosure
Course Director and Interviewee
Rhonda R. Voskuhl, MD
Professor, Department of Neurology
Director, Multiple Sclerosis Program
University of California Los Angeles School of Medicine
Los Angeles, California
Rhonda R. Voskuhl, MD,
has a financial interest/relationship or affiliation in the form of:
Consultant for Pipex Pharmaceuticals, Inc.
Grant/Research Support from National Institutes of Health/National Multiple Sclerosis Society to study estriol treatment in multiple sclerosis.
Interviewee
Ralph H. B. Benedict, PhD
Professor, Neurology, Psychiatry and Psychology
Jacobs Neurological Institute, SUNY Buffalo School of Medicine
Buffalo, New York
Ralph H. B. Benedict, PhD,
has a financial interest/relationship or affiliation in the form of:
Consultant for Bayer Corporation; Biogen Idec Inc.; Merck & Co., Inc.; and Novartis Pharmaceuticals Corporation.
Grant/Research Support from National Institutes of Health; National Multiple Sclerosis Society; and Shire.
Speakers Bureau participant with Abbott Laboratories; Bayer Corporation; and Biogen Idec Inc.
CME Reviewer
Sheldon Jordan, MD
Neurologist, Pain Medicine
Neurological Associates
Santa Monica, California
Sheldon Jordan, MD,
currently has no financial interests/relationships or affiliations in relation to this activity.
CNE Reviewer
Andrew Leuchter, MD
David Geffen School of Medicine at UCLA
Semel Institute for Neuroscience and Human Behavior at UCLA
Los Angeles, California
Content Director
Kadrin Wilfong, MD
PVI, PeerView Institute for Medical Education, Inc.
Kadrin Wilfong, MD,
currently has no financial interests/relationships or affiliations in relation to this activity.
Sponsorship, Credit & Support
Physicians
This program was developed and reviewed by faculty members of the David Geffen School of Medicine at UCLA. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Institute for Medical Education and the Semel Institute for Neuroscience and Human Behavior at UCLA, in association with PVI, PeerView Institute for Medical Education. The Institute for Medical Education takes responsibility for the content, quality and scientific integrity of this CME activity.
The Institute for Medical Education designates this educational activity for a maximum of 0.5 hour of AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
Nurses
The Semel Institute at UCLA is an accredited provider for continuing education credits for nurses (provider number CEP381). This course meets the qualifications for 0.5 hour of credit as required by the Board of Registered Nursing.
Note: Not all state nursing boards will accept programs less than 1.0 hour in length for credit. Please click here to find out the status of your state.
This activity is supported by an educational grant from 
